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had symptomatic intracerebral hemorrhage. DWI-ASPECTS was 6 (5-9). DR was seen in 16 (24%) and 26 (39%) patients at 24 hours and on day 7, respectively. Early recanalization occurred in 22 (33%) patients. The online-only Supplemental Tables 1 and 2 show the clinical characteristics of patients with and without DR at 24 hours and 7 days, and Figure 1 †Adjusted for gender, NIHSS score, AF, anticoagulation therapy, hemoglobin, d-dimer, ICAO, M1-SVS, and systolic blood pressure.
Figure 1. A, In patients with diffusion-weighted imaging-the Alberta Stroke Program Early
Computed Tomography Score (DWI-ASPECTS) ≥7, 5 (24%) of 21 patients without early recanalization and 9 (82%) of 11 patients with early recanalization had dramatic recovery (DR) at 24 hours (P=0.003); and B, 11 (52%) of 21 patients without early recanalization and 9 (82%) of 11 patients with early recanalization had DR at 7 days (P=0.139). C, In patients with DWI-ASPECTS <7, only 2 (18%) of 11 patients with early recanalization had DR at 24 hours (P=0.098); and D, 1 (4%) of 23 patients without early recanalization and 5 (45%) of 11 patients with early recanalization had DR at 7 days (P=0.008).
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shows the association of DR at 24 hours and 7 days as well as clinical outcome at 3 months with DWI-ASPECTS. DWI-ASPECTS ≥7 was found to be the cut-off that could identify the DR at 24 hours and 7 days (sensitivity of 0.88 and 0.77, specificity of 0.64 and 0.70, and area under curve of 0.771 and 0.743, respectively, all P=0.001). Multivariate analysis revealed that DWI-ASPECTS ≥7 was an independent predictor of DR both at 24 hours and 7 days (Table) . In patients with DWI-ASPECTS ≥7, early recanalization was associated with DR at 24 hours. In those with DWI-ASPECTS <7, early recanalization was related to DR at 7 days ( Figure 1 Favorable outcome was seen in 14 (26%) of 54 patients with a premorbid mRS of 0 to 2. The rate of favorable outcome in patients with DWI-ASPECTS ≥7 was not associated with early recanalization. To the contrary, out of all of the patients without early recanalization, none of the patients with DWI-ASPECTS <7 had a favorable outcome (Figure 2 ).
Discussion
DWI-ASPECTS ≥7 was an independent predictor of shortterm neurological recovery after an M1-MCAO. Limited DWI changes before IV-tPA have been reported as a predictor of neurological recovery. 4 Presence of a clinical-DWI mismatch defined as DWI-ASPECTS ≥7 and an NIHSS score ≥8 has also been reported to be predictors of neurological recovery after IV-tPA. 5 An advantage of our study is that the utility of DWI-ASPECTS was evaluated after adjusting for several established imaging and laboratory parameters. Although early recanalization was associated with DR in patients with DWI-ASPECTS ≥7 and <7, its role regarding clinical and radiological outcomes depended on the initial DWI-ASPECTS. In patients with DWI-ASPECTS ≥7, the favorable outcome rate and follow-up infarct volume were not statistically different between patients with and without early recanalization. To the contrary, in patients with DWI-ASPECTS <7, favorable outcomes were only seen in patients with early recanalization. Early recanalization also led to smaller infarct volumes at day 7, despite that these infarcts were still large. These results indicate that in patients with lower DWI-ASPECTS there may be no benefit to delayed recanalization, whereas there may still be benefit from early recanalization. The combination of IV-tPA and intra-arterial intervention has attracted significant attention attributable to the resultant increase in the early recanalization rate. Administration of a free radical scavenger might also elevate the rate of early recanalization. 6 Immediate combination of these therapies may provide better outcomes in patients with lower DWI-ASPECTS.
There are several limitations to the present study. The number of patients was small and most patients were older. A tPA dose of 0.6 mg/kg was used (based on the Japanese guideline), and patients with off-label use of IV-tPA were also enrolled. The rate of recanalization was high, possibly because recanalization was assessed using magnetic resonance angiography. Because the patients were simply divided into 2 groups based on the DWI-ASPECTS cut-off of 7, the exact relationship of DWI-ASPECTS with early recanalization regarding short-term recovery and clinical and radiological outcomes is unclear.
In conclusion, DWI-ASPECTS predicted short-term neurological recovery in patients with M1-MCAO after receiving IV-tPA. In patients with lower DWI-ASPECTS, early recanalization was associated with functional independence at 3 months after stroke.
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Methods
The following clinical information of the enrolled patients was obtained: age; sex; time from onset to treatment; modified Rankin Scale (mRS) score before stroke; vascular risk factors; atrial fibrillation; past antithrombotic medication; blood pressure before intravenous thrombolysis using recombinant tissue plasminogen activator (IV-tPA); stroke etiology; and presence of cardiac sources of emboli. Time from onset to treatment was automatically defined as 3 h in patients with unknown onset time treated with IV-tPA based on diffusion-weighted imaging (DWI)/fluid-attenuated inversion recovery (FLAIR) mismatch. Vascular risk factors were identified as follows : 1) hypertension, a history of using antihypertensive agents, a systolic blood pressure ≥140 mmHg, or a diastolic blood pressure ≥90 mmHg at hospital discharge; 2) diabetes mellitus, use of hypoglycemics, random glucose level of ≥200 mg/dl, or glycosylated hemoglobin >6.4% on admission; and 3) hyperlipidemia, use of antihyperlipidemic agents or serum cholesterol level >220 mg/dl. Medications taken before admission were documented. Anticoagulation was performed using warfarin sodium. Aspirin, ticlopidine, clopidogrel, and cilostazol were given as antiplatelet therapy.
Stroke etiology was determined at hospital discharge using Trial of ORG 10172
in Acute Stroke Treatment criteria: 1) small-vessel occlusion; 2) large-artery atherosclerosis; 3) cardioembolism; or 4) other or undetermined etiology of stroke.
Duplex ultrasonography was performed in all patients to assess the common and internal carotid arteries. To assess the presence of cardiac sources of emboli, transcranial Doppler, transthoracic echocardiography examination and Holter electrocardiography were also performed. Transesophageal echocardiography and conventional cerebral angiography were performed if appropriate.
All patients were evaluated using 1.5 T magnetic resonance (MR) imaging on admission, and at 1 h and 7 days after IV-tPA. DWI was obtained using the following Results were considered significant when P<0.05. Table S1 . Clinical characteristics and imaging findings between DR and non-DR groups at 24 h.
SUPPLEMENTAL TABLES
DR indicates dramatic recovery; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; IV-tPA, intravenous thrombolysis using recombinant tissue plasminogen activator; LDL, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1c; CRP, C-reactive protein; M1-MCAO, horizontal portion of the middle cerebral artery; ICAO, internal carotid artery occlusion; DWI-ASPECTS, diffusion-weighted imaging-Alberta Stroke Programme Early Computed Tomography Score; M1-SVS, M1 susceptibility vessel sign. *One patient did not evaluated with magnetic resonance angiography 24 h after IV-tPA. 
